'Avalanche of diabetes' undermines economies worldwide, Novo Nordisk CFO says
November 01, 2017 at 07:35 AM EDT
An inexorable global rise in diabetes must be taken "more seriously" by society, according to the CFO at the world's top maker of diabetes drugs.
